I had invested earlier in it, but exited due to trademark litigations issue. Company should perform good but there will always be a regulatory issue with the trademark.
Posts in category Value Pickr
Rajshree Polypack – The food packaging specialist (16-11-2023)
Q2FY24:
• Volume growth 17% yoy.
• Injection Moulding: In process of machine upgradation to enhance installed capacity.
• Developed 6 new products
15 new customers onboarded including 4 overseas customers.
Strong Customer retention with ~97% of revenue from repeat customers.
• Appointed Chief Marketing Officer.
• Company’s export revenue tripled on Y-o-Y basis to ₹15.32 Crores for H1FY24.
• Around 55-60% of the business is coming from dairy and beverages.
• Injection molding capacity expansion: It is in discussion phase as such. As and when it materializes, will let you know the exact numbers.
• Patents: One is a process patent which we have done for making the tube laminates, that’s a process patent which we are holding. The other is product packaging design patent which we are holding.
• Tube laminates: We are constantly evaluating this particular market so as and when we feel that the situation is correct to have a dedicated line for this particular segment, we will take a call for investing for a dedicated line for the tube lamination. At the moment, it is on halt.
• Over the period of 2-3 years, we expect it to at least go to 12 crores to 15 crores per quarter or at least Rs. 50crores- Rs. 60crores coming from export.
• In-Mold Label: In-Mold Label, we have commercially established the product and we have started manufacturing. We have received the initial trial orders from the customers and we will ramp up the production of IML products in coming quarters. So, that is the six products of what we have added in which that one of the products is Injection Molded product, Label products.
• Olive Ecopack: Rs. 100 crores- Rs. 110 crores revenue we can definitely look for next year. that number will be a break-even number.
• So, for next quarter, definitely, we’ll see the reduction in the Finance Cost.
• Customer advance for capex: It will be difficult to reveal the name of the customer but, yes, as I mentioned that few of the customers where we have almost monopolistic supply and as the customer is expanding their business, they wanted us also to increase the capacities and it helped us in increasing the capacities as we were doing a lot of investment and we needed that support and they accepted our request. That’s the only thing, I would say.
• In food packaging, since sustainable packaging still are not able to meet the functional requirement, we don’t see much entry of sustainable products entering into Food Packaging but there the more focus will be on to recyclability and using recycled materials. And in Food Service, the focus will be more on using sustainable products. And we would say, as a company we are well placed in both the sectors and so that will help us to achieve the growth in the next five years
• Capacity increase: we are working on increasing the capacities on the existing machines by doing some modifications and we have got very good results and probably in the next one month or so we should be able to announce that the increment in the installed capacity on these processes around 10%-15%.
The Anti-Portfolio (16-11-2023)
Hi Sandy, thanks! I don’t have much of an opinion, there are 2-3 business areas they operate in, remember having invested before (for hardly one quarter). Results are on very good uptrend so you can maybe keep holding. I didn’t find conviction to make big enough holding, since it was also highly valued then.
Disclaimer : Am not an sebi analyst/advisor, this is not a stock recommendation
Som Distilleries and Breweries (16-11-2023)
The points you mentioned do play a role but you are missing out on the most common reason behind promoter buying – Foreseeable earnings growth which in turn raises the stock price and makes the promoter’s net worth go zoom and buying usually happens a couple of quarters before unusual growth in numbers.
E2E Networks Ltd – Listed small Cloud computing player (16-11-2023)
Thanks for the update but given that E2E is having upper circuit everyday doesn’t it looks like some thing fishy.
Also how one can buy in upper circuit…
Note : I bought it at 168 but not happy with upper circuit everyday sold at 400 something
Rajesh Exports: Time to examine this story seriously? (16-11-2023)
The probable reason on why it continues to slide.
https://twitter.com/BeatTheStreet10/status/1724706663427609010?t=WICbzsR74OF3bz6RYc704Q&s=19
Carysil (earlier Acrysil) – Kitchen sinks (16-11-2023)
My understanding for the questions you asked:-
- The COGS is lower in this quarter and management expects it to stabilise in a similar range. Also, the new customer acquisitions in the export market along with IKEA order should also help the margins to sustain above 20%.
- I personally did not read about increasing volume inventory. However, they did mention about a strong dealer network and the fact that showrooms have gone up from 10 to 60 in the domestic market. On the back of this, they are targeting 200Cr domestic sales and this should reflect from Q3
- The management corrected that B/S shows higher debtor days as UK Tap company acquition is integrated this quarter and that reflects in receivables and debtor days.
Disclaimer: This is just my personal understanding from the Company Concall
Omkar’s Portfolio Analysis and Discussion (15-11-2023)
Tagging the first note on this topic mentioned on the thread
Omkar’s Portfolio Analysis and Discussion (15-11-2023)
Portfolio Update
As discussed earlier in this thread, i am looking to build large allocation ( 25-30%) to Tier 1 financials. Building large concentrated sectoral allocation in banks has following odds in favour according to my judgement
- Potential to grow earnings at high teens percentage and that too consistently. These 2 factors – high teens earnings growth and consistency – align well with my long term portfolio return expectations of high teen to twenty % with buy and hold approach
- Valuations are comfortable and higher odds of bottoming of derating cycle
- Improves the large cap allocation of the portfolio which further improves the ability to ‘hold’ small mid cap positions
- Not trying to be adventurous in financials because – usually in financials down cycle leaves so much ‘scarring’ that investor becomes reluctant to allocate any money to financials in future cycles thereby missing high teens long term easy compounding story
- Overall I believe this trade has descent risk reward and not asymmetric risk reward which is ok because for my abilities and temperament current environment is not a wicket to hit fours and sixes
- Eventual allocation will have equal weights of around 6-8% to – hdfc bank, icici bank, kotak bank and bajaj finserv
Current portfolio
Suprajit | 20.96% |
---|---|
Ajanta pharma | 20.17% |
Kotak bank | 7.53% |
Hdfc bank | 3.60% |
Bajaj finserv | 3.40% |
Abbott india | 3.18% |
ICICI bank | 3.03% |
HCL Tech | 2.64% |
Mutual funds | 35.4% |
Bull therapy 101-thread for technical analysis with the fundamentals (15-11-2023)
@phreakv6 Any views on the same ?